Viewing StudyNCT00881816



Ignite Creation Date: 2024-05-05 @ 9:25 PM
Last Modification Date: 2024-10-26 @ 10:04 AM
Study NCT ID: NCT00881816
Status: UNKNOWN
Last Update Posted: 2009-04-15
First Post: 2009-04-14

Brief Title: Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma
Sponsor: Nanjing Sike Pharmaceutical Co Ltd
Organization: Nanjing Sike Pharmaceutical Co Ltd

Conditions & Keywords Data

Conditions:
Name
Advanced Gastric Carcinoma
Keywords:
Name View
Dose limiting toxicity View
Liposomal Paclitaxel View
Capecitabine View
Maximum tolerated dose View